(10-009) Outcomes with Full Versus Reduced Dose Rivaroxaban and Apixaban After Initial Venous Thromboembolism Treatment
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: Kaiser Foundation Health Plan of Georgia, Inc. Residency Program Type: PGY1 (Managed Care Pharmacy) Residency Program Location: Georgia
Co-Author(s): Sweta M. Patel, Irene Robb, Naomi Yates
